002793.SZ · 罗欣药业
China A-shares · RS rating 76 · As of 2026-10-14
| Price | 4.68 CNY |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 76 / 71 / 60 / 58 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 34 / 41 / 28 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -3.1% |
| Distance from 52-week high | +18.9% |
| Market cap (USD) | $795.4M |